1. Home
  2. RGEN vs BSAC Comparison

RGEN vs BSAC Comparison

Compare RGEN & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$161.91

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Banco Santander - Chile ADS

BSAC

Banco Santander - Chile ADS

HOLD

Current Price

$36.09

Market Cap

17.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
BSAC
Founded
1981
1977
Country
United States
Chile
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
17.0B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
RGEN
BSAC
Price
$161.91
$36.09
Analyst Decision
Buy
Hold
Analyst Count
11
2
Target Price
$177.18
$29.50
AVG Volume (30 Days)
577.2K
311.3K
Earning Date
02-19-2026
01-30-2026
Dividend Yield
N/A
2.74%
EPS Growth
N/A
22.83
EPS
0.03
0.01
Revenue
$707,890,000.00
$2,560,142,282.00
Revenue This Year
$17.86
$35.78
Revenue Next Year
$12.44
$6.84
P/E Ratio
$5,257.58
$14.42
Revenue Growth
11.74
10.15
52 Week Low
$102.97
$19.66
52 Week High
$182.52
$36.19

Technical Indicators

Market Signals
Indicator
RGEN
BSAC
Relative Strength Index (RSI) 45.60 75.88
Support Level $157.29 $32.17
Resistance Level $174.87 $33.34
Average True Range (ATR) 7.07 0.81
MACD -0.52 0.28
Stochastic Oscillator 23.05 98.65

Price Performance

Historical Comparison
RGEN
BSAC

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: